Poland· PL-100418297

Bixebra

A ivabradine product containing ivabradinum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 19 of our 19 countries.

ATC C01EB17

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBixebraATCC01EB17REGISTER NO.PL-100418297PACKS LISTED5CHECKEDSeptember 27, 2026

Where it is registered

Ivabradine is registered in 19 of 19 countries.

Countries holding a registration under ATC C01EB17 (ivabradine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose

Ivabradine · ATC C01EB17

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ivabradine costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.59 in France to $1.75 in Switzerland — a ×2.9 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ivabradine · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.75
  • ES Spain$1.17
  • IT Italy$0.81
  • FR France$0.59
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Ivabradinum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
C01EB17
ATC class
Ivabradine
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991398040
  • gtin
    05909991398057
  • gtin
    05909991398064
  • gtin
    05909991398071
  • gtin
    05909991398088

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

203 interactions on record for ivabradine.

Graded by severity as the source publishes them — 128 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ivabradine · interactions on record

203 records

  • 128 severe
  • 61 moderate

Most severe, free to view

  • ClotrimazoleA01AB18severe
  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe

14 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ivabradine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ivabradine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Ivabradin Aristo, Ivabradin Genericon
  • Belgium · Ivabradine Ab, Ivabradine Krka
  • Bulgaria · Апредонав, Биксебра
  • Cyprus · Apredonav, Bivelen
  • Czechia · Bixebra, Ivabradin Teva
  • Germany · Ivabalan, Ivabradin 1 A Pharma
  • Denmark · Ivabradin Krka, Ivabradin Medical Valley
  • Estonia · Brediwal
  • Spain · Apredonav, Ivabradina Alter
  • France · Ivabradine Alter, Ivabradine Arrow
  • United Kingdom (Northern Ireland) · Ivabradine, Ivabradine Amarox
  • Greece · Apredonav, Bravigo
  • Croatia · Bixebra
  • Hungary · Bravadin, Inevica
  • Ireland · Ivabradine Krka, Ivabradine Rowex
  • Iceland · Corlentor, Ivabradine Accord
  • Italy · Ivabradina Aurobindo, Ivabradina Doc Generici
  • Liechtenstein · Corlentor, Ivabradine Accord
  • Lithuania · Apredonav, Bixebra
  • Latvia · Apredonav, Bixebra
  • Malta · Apredonav
  • Netherlands · Ivabradine Amarox, Ivabradine Aurobindo
  • Norway · Corlentor, Ivabradine Accord
  • Portugal · Bluepharma Bluesar, Ivabradina Alter
  • Romania · Apredonav, Bixebra
  • Sweden · Ivabradin Krka, Ivabradin Medical Valley
  • Slovenia · Apredonav, Bixebra
  • Slovakia · Bixebra, Ivabradin Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f3721490-1aba-46ea-a98f-b2b448c71750
GET /v1/drugs/f3721490-1aba-46ea-a98f-b2b448c71750?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "5 mg",
  "packaging": "05909991398040 ¦ Rp ¦ 131998\n14 tabl.\n05909991398057 ¦ Rp ¦ 131999\n28 tabl.\n05909991398064 ¦ Rp ¦ 132000\n56 tabl.\n05909991398071 ¦ Rp ¦ 132001\n98 tabl.\n05909991398088 ¦ Rp ¦ 132002\n112 tabl.",
  "substance": "Ivabradinum 5 mg",
  "common_name": "Ivabradinum",
  "pl_product_id": "100418297",
  "pozwolenie_nr": "115/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-03-21"
}

See everything about ivabradine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.